News
- Author:
- Nancy A. Melville
Publish date: October 26, 2023
Mortality rates from early-stage ocular MALT lymphoma are low, with relapse rates lowered by radiation therapy.
News
- Author:
- Nancy A. Melville
Publish date: October 11, 2023
The implication is that nonsurgical options such as radiofrequency ablation may be appropriate for more patients than realized.
News
- Author:
- Nancy A. Melville
Publish date: October 6, 2023
“I would characterize the trends in our data as being potentially suggestive or hypothesis generating – not conclusive.”
News
- Author:
- Nancy A. Melville
Publish date: October 4, 2023
“While we can never assume that [the events occurred] because the blood-thinner therapy was held, the timing within 48 hours is certainly very susp...
News
- Author:
- Nancy A. Melville
Publish date: October 2, 2023
"The very long median overall survival in the study's neoadjuvant group is quite remarkable for a group of patients who used to have a very poor pr...
News
- Author:
- Nancy A. Melville
Publish date: September 28, 2023
“A typical indication is fracture detection, not in terms of replacing expert radiologists or orthopedists but rather in terms of supporting those ...
News
- Author:
- Nancy A. Melville
Publish date: September 28, 2023
Among clinicians and their patients, widespread myths about sickle cell disease can stand in the way of adequate treatment.
News
- Author:
- Nancy A. Melville
Publish date: September 27, 2023
A Nigerian-American hematologist draws on her experience living with sickle cell disease to encourage child patients and advise colleagues.
News
- Author:
- Nancy A. Melville
Publish date: September 26, 2023
Given the array of potential obstacles to endocrine therapy adherence, improving long-term use may be equally complex.
News
- Author:
- Nancy A. Melville
Publish date: September 25, 2023
“Although the efficacy of the high tirzepatide dose might make it a favorable choice, its real-world application can be affected on an individual’s...
News
- Author:
- Nancy A. Melville
Publish date: September 20, 2023
“Probably the greatest concern shared by the writing group on this statement was the potential for clinicians to start ablation practices without h...
News
- Author:
- Nancy A. Melville
Publish date: September 7, 2023
The correlation between BCR-free survival and overall survival ranged from low to moderate.
News
- Author:
- Nancy A. Melville
Publish date: August 31, 2023
About one in five cancer survivors report experiencing financial toxicity, but financial monitoring is not a routine part of clinical care.
News
- Author:
- Nancy A. Melville
Publish date: August 31, 2023
The subcutaneous drug concizumab could be an important first treatment for hemophilia B with inhibitors; FDA resubmission is planned.
News
- Author:
- Nancy A. Melville
Publish date: August 24, 2023
After donor stem cell transplants, children with lower gut microbiota diversity show poorer survival and more complications.
